Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers

• Evelo Biosciences, Inc. (NASDAQ:EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
• ContraFect Corporation (NASDAQ:CFRX) gained 87% to $2.4693. ContraFect said first patient was dosed in the Phase 1b/2 study of exebacase in patients with chronic prosthetic joint infections of the knee.
• Hillstream BioPharma, Inc. (NASDAQ:HILS) jumped 56% to $1.10.
• TOP Financial Group Limited (NASDAQ:TOP) rose 53.7% to $10.33.
• U Power Limited (NASDAQ:UCAR) climbed 33.5% to $5.45 after declining around 27% on Wednesday.
• Atomera Incorporated (NASDAQ:ATOM) shares gained 23.6% to $6.45 after the company posted results for its first quarter. The company announced the execution of a commercial license agreement with STMicroelectronics (ST) that enables the latter to install Atomera's Mears Silicon Technology into its facilities.
• OMNIQ Corp. (NASDAQ:OMQS) climbed 20.8% to $5.47.
• Vapotherm, Inc. (NYSE:VAPO) rose 19.4% to $0.5001.
• Helen of Troy Limited (NASDAQ:HELE) shares gained 19.1% to $97.39 after the company announced better-than-expected Q4 results.
• Nuburu, Inc. (NYSE:BURU) gained 19% to $1.13.
• Bel Fuse Inc. (NASDAQ:BELFB) rose 18.3% to $36.25 following better-than-expected quarterly results.
• Immuron Limited (NASDAQ:IMRN) gained 16.4% to $2.23.
• CXApp Inc. (NASDAQ:CXAI) climbed 16% to $10.74.
• Mainz Biomed N.V. (NASDAQ:MYNZ) gained 15.6% to $3.92.
• Accuray Incorporated (NASDAQ:ARAY) jumped 15% to $3.1050 after the company reported better-than-expected Q3 EPS and sales results.
• LianBio (NASDAQ:LIAN) rose 14.7% to $2.26. LianBio announced topline results from the Phase 3 EXPLORER-CN trial investigating mavacamten for Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
• Meta Platforms, Inc. (NASDAQ:META) climbed 14.3% to $239.64 as the company reported better-than-expected Q1 results and also announced an increase in active users.
• Immix Biopharma, Inc. (NASDAQ:IMMX) gained 14.1% to $2.13 after Nexcella, an Immix Biopharma subsidiary, disclosed positive 58-patient NXC-201 clinical data.
• GRI Bio, Inc. (NASDAQ:GRI) gained 14.1% to $6.79.
• Goosehead Insurance, Inc (NASDAQ:GSHD) jumped 13.8% to $61.15 following upbeat quarterly results.
• Overstock.com, Inc. (NASDAQ:OSTK) rose 13.7% to $20.54 following strong quarterly results.
• Ardagh Metal Packaging S.A. (NYSE:AMBP) gained 13.5% to $3.93 following Q1 results.
• Materialise NV (NASDAQ:MTLS) gained 13% to $8.80 as the company posted upbeat Q1 results and named Koen Berges as CFO.
• Cimpress plc (NASDAQ:CMPR) jumped 12.4% to $48.72 following strong quarterly sales.
• Hasbro, Inc. (NASDAQ:HAS) gained 10.8% to $57.00 after the company reported better-than-expected Q1 sales results and reiterated FY23 adjusted EPS guidance above the estimate.
• Mangoceuticals, Inc (NASDAQ:MGRX) surged 10.7% to $1.3418 after dropping around 33% on Wednesday. Mangoceuticals recently commenced online sales campaign with DojoLabs Group.
• Getaround, Inc. (NYSE:GETR) climbed 9.9% to $0.4999. Getaround received continued listing standard notice from NYSE related to delayed filing of Form 10-K.
• Kaiser Aluminum Corporation (NASDAQ:KALU) gained 9.7% to $63.82 following Q1 results.
• OpGen, Inc. (NASDAQ:OPGN) gained 6% to $0.88 after the company said its German subsidiary Curetis GmbH has met the remaining key milestones under the initial research and development collaboration agreement with FIND.

Losers

• Baudax Bio, Inc. (NASDAQ:BXRX) fell 52.5% to $0.8406 after the company reported the pricing of $4 million public offering.
• Impinj, Inc. (NASDAQ:PI) dropped 35.2% to $87.71 after the company reported mixed Q1 results and issued weak guidance.
• 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) shares fell 31.1% to $14.18. 4DMT presented interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial in patients with wet AMD at ARVO 2023.
• Aspen Technology, Inc. (NASDAQ:AZPN) fell 25% to $173.76 after the company posted downbeat Q3 results and issued weak FY23 forecast.
• Mobileye Global Inc. (NASDAQ:MBLY) dropped 22% to $33.58 after the company lowered FY23 revenue guidance below estimates.
• Crown ElectroKinetics Corp. (NASDAQ:CRKN) fell 20.6% to $0.1206. Crown Electrokinetics recently issued a letter to shareholders.
• Satixfy Communications Ltd. (NYSE:SATX) dropped 19.8% to $0.8101.
• PROCEPT BioRobotics Corporation (NASDAQ:PRCT) fell 19.2% to $28.89 following wider-than-expected Q1 loss.
• Crocs, Inc. (NASDAQ:CROX) fell 18.5% to $120.35 after the company reported Q1 earnings results and after the company issued Q2 guidance.
• ETAO International Co., Ltd. (NASDAQ:ETAO) shares dropped 18.3% to $0.96 after gaining around 57% on Wednesday.
• NETGEAR, Inc. (NASDAQ:NTGR) dipped 18.1% to $13.77 following weak quarterly results.
• Ideanomics, Inc. (NASDAQ:IDEX) fell 17.2% to $0.0227 after dropping around 22% on Wednesday.
• Kuke Music Holding Limited (NYSE:KUKE) dropped 16.9% to $0.60.
• Wolfspeed, Inc. (NYSE:WOLF) fell 16.2% to $48.11 after the company issued weak Q4 guidance.
• Avinger, Inc. (NASDAQ:AVGR) fell 15.5% to $0.54.
• MaxLinear, Inc. (NYSE:MXL) dipped 15.5% to $24.78 after the company issued weak Q2 guidance.
• IN8bio, Inc. (NASDAQ:INAB) fell 13.3% to $1.6902. IN8bio announced oral presentation of new INB-200 Phase 1 data in glioblastoma to be presented at 2023 ASCO Annual Meeting.
• H&E Equipment Services, Inc. (NASDAQ:HEES) declined 12% to $36.36 following Q1 results.
• Align Technology, Inc. (NASDAQ:ALGN) fell 11.7% to $312.85 after the company reported Q1 financial results and issued guidance.
• Opera Limited (NASDAQ:OPRA) dropped 11.6% to $10.04 following Q1 results.
• Sonic Automotive, Inc. (NYSE:SAH) gained 11.3% to $46.28 following weak quarterly results.
• American Rebel Holdings, Inc. (NASDAQ:AREB) shares fell 11% to $0.1371 after gaining around 14% on Wednesday.
• National Energy Services Reunited Corp. (NASDAQ:NESR) dipped 11% to $2.94 after the company announced it was not able to file its Annual Report on Form 20-F for its fiscal year ended December 31, 2021 with the SEC.
• Clearmind Medicine Inc. (NASDAQ:CMND) fell 10.5% to $0.62. CONMED said it sees FY23 EPS of $3.30 to $3.50 and revenue of $1.205 billion to $1.250 billion.
• Morningstar, Inc. (NASDAQ:MORN) dropped 9.3% to $172.95 following Q1 results.
• AbbVie Inc. (NYSE:ABBV) dropped 8.5% to $147.95 after the company reported Q1 financial results and issued FY23 guidance.
• Mobiquity Technologies, Inc. (NASDAQ:MOBQ) fell 8.4% to $0.1718 after jumping 22% on Wednesday. Mobility Technologies recently announced its AI-powered ad targeting technology.
• STMicroelectronics N.V. (NYSE:STM) shares dropped 8.4% to $42.37 after reporting Q1 results.

Now Read This: Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter